DK0433167T3 - Hidtil ukendte piperidinderivater, fremgangsmåde til fremstilling heraf og farmaceutiske midler indeholdende dem - Google Patents
Hidtil ukendte piperidinderivater, fremgangsmåde til fremstilling heraf og farmaceutiske midler indeholdende demInfo
- Publication number
- DK0433167T3 DK0433167T3 DK90403537.5T DK90403537T DK0433167T3 DK 0433167 T3 DK0433167 T3 DK 0433167T3 DK 90403537 T DK90403537 T DK 90403537T DK 0433167 T3 DK0433167 T3 DK 0433167T3
- Authority
- DK
- Denmark
- Prior art keywords
- image
- piperidine derivatives
- processes
- preparation
- pathology
- Prior art date
Links
- 150000003053 piperidines Chemical class 0.000 title abstract 2
- 239000008177 pharmaceutical agent Substances 0.000 title 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 2
- 239000005864 Sulphur Substances 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 2
- 229910052760 oxygen Inorganic materials 0.000 abstract 2
- 239000001301 oxygen Substances 0.000 abstract 2
- 230000007170 pathology Effects 0.000 abstract 2
- 125000001424 substituent group Chemical group 0.000 abstract 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 125000001183 hydrocarbyl group Chemical group 0.000 abstract 1
- 150000002431 hydrogen Chemical class 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 230000000977 initiatory effect Effects 0.000 abstract 1
- 208000028867 ischemia Diseases 0.000 abstract 1
- 230000003859 lipid peroxidation Effects 0.000 abstract 1
- 230000002093 peripheral effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 230000006439 vascular pathology Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/54—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8916384A FR2655649B1 (fr) | 1989-12-12 | 1989-12-12 | Nouveaux derives de la piperidine, leur procede de preparation et les compositions pharmaceutiques les renfermant. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0433167T3 true DK0433167T3 (da) | 1994-05-02 |
Family
ID=9388394
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK90403537.5T DK0433167T3 (da) | 1989-12-12 | 1990-12-12 | Hidtil ukendte piperidinderivater, fremgangsmåde til fremstilling heraf og farmaceutiske midler indeholdende dem |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US5126356A (da) |
| EP (1) | EP0433167B1 (da) |
| JP (1) | JPH07100695B2 (da) |
| AT (1) | ATE102186T1 (da) |
| AU (1) | AU629076B2 (da) |
| CA (1) | CA2031839A1 (da) |
| DE (1) | DE69007045T2 (da) |
| DK (1) | DK0433167T3 (da) |
| ES (1) | ES2052217T3 (da) |
| FR (1) | FR2655649B1 (da) |
| IE (1) | IE66909B1 (da) |
| NZ (1) | NZ236231A (da) |
| OA (1) | OA09473A (da) |
| PT (1) | PT96156B (da) |
| ZA (1) | ZA909768B (da) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU214331B (hu) * | 1992-06-17 | 1998-03-02 | Gyógyszerkutató Intézet Kft. | Eljárás piperazin- és homopiperazinszármazékok és ezeket tartalmazó gyógyszerkészítmények előállítására |
| JPWO2003099788A1 (ja) * | 2002-05-28 | 2005-09-22 | 日本ケミファ株式会社 | ピペリジン誘導体 |
| WO2005030721A1 (ja) * | 2003-09-30 | 2005-04-07 | Nippon Chemiphar Co., Ltd. | ピペリジン誘導体 |
| EP3316877B1 (en) | 2015-07-02 | 2019-10-30 | Horizon Orphan LLC | Ado-resistant cysteamine analogs and uses thereof |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB780027A (en) * | 1955-01-20 | 1957-07-31 | Schering Corp | 3-piperidyl ethers and thioethers |
| FR2514353A2 (fr) * | 1980-04-28 | 1983-04-15 | Synthelabo | Derives de piperidine et leur application en therapeutique |
| EP0077427B1 (fr) * | 1981-10-15 | 1985-05-22 | Synthelabo | Dérivés de pipéridine, leur procédé de préparation et leur application en thérapeutique |
| US4529730A (en) * | 1981-10-21 | 1985-07-16 | Synthelabo | Piperidine derivatives, their preparation and pharmaceutical compositions containing them |
| GB8321157D0 (en) * | 1983-08-05 | 1983-09-07 | Fordonal Sa | Piperidine derivatives |
| ZA848275B (en) * | 1983-12-28 | 1985-08-28 | Degussa | New piridine-2-ethers or pyridine-2-thioethers having a nitrogen-containing cycloaliphatic ring |
-
1989
- 1989-12-12 FR FR8916384A patent/FR2655649B1/fr not_active Expired - Fee Related
-
1990
- 1990-11-27 NZ NZ236231A patent/NZ236231A/en unknown
- 1990-12-05 ZA ZA909768A patent/ZA909768B/xx unknown
- 1990-12-07 CA CA002031839A patent/CA2031839A1/fr not_active Abandoned
- 1990-12-10 IE IE443490A patent/IE66909B1/en not_active IP Right Cessation
- 1990-12-11 PT PT96156A patent/PT96156B/pt not_active IP Right Cessation
- 1990-12-11 AU AU67936/90A patent/AU629076B2/en not_active Ceased
- 1990-12-11 US US07/625,422 patent/US5126356A/en not_active Expired - Fee Related
- 1990-12-12 ES ES90403537T patent/ES2052217T3/es not_active Expired - Lifetime
- 1990-12-12 OA OA59915A patent/OA09473A/xx unknown
- 1990-12-12 AT AT90403537T patent/ATE102186T1/de active
- 1990-12-12 EP EP90403537A patent/EP0433167B1/fr not_active Expired - Lifetime
- 1990-12-12 JP JP2419227A patent/JPH07100695B2/ja not_active Expired - Lifetime
- 1990-12-12 DE DE69007045T patent/DE69007045T2/de not_active Expired - Fee Related
- 1990-12-12 DK DK90403537.5T patent/DK0433167T3/da active
Also Published As
| Publication number | Publication date |
|---|---|
| DE69007045D1 (de) | 1994-04-07 |
| FR2655649B1 (fr) | 1994-07-08 |
| PT96156A (pt) | 1991-09-30 |
| EP0433167A1 (fr) | 1991-06-19 |
| DE69007045T2 (de) | 1994-08-04 |
| ES2052217T3 (es) | 1994-07-01 |
| CA2031839A1 (fr) | 1991-06-13 |
| OA09473A (fr) | 1992-11-15 |
| JPH06340626A (ja) | 1994-12-13 |
| PT96156B (pt) | 1998-05-29 |
| NZ236231A (en) | 1992-07-28 |
| ZA909768B (en) | 1991-09-25 |
| FR2655649A1 (fr) | 1991-06-14 |
| IE904434A1 (en) | 1991-06-19 |
| US5126356A (en) | 1992-06-30 |
| JPH07100695B2 (ja) | 1995-11-01 |
| AU629076B2 (en) | 1992-09-24 |
| AU6793690A (en) | 1991-06-20 |
| EP0433167B1 (fr) | 1994-03-02 |
| IE66909B1 (en) | 1996-02-07 |
| ATE102186T1 (de) | 1994-03-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE40368T1 (de) | Xanthin-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
| KR950700265A (ko) | 고지혈증 치료에 유용한 벤조티아제핀 화합물(hypolipidaemic ben zothiazepine compounds) | |
| NO810684L (no) | Fremgangsmaate ved fremstilling av indanderivater. | |
| ATE17728T1 (de) | Xanthinderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
| ATE111912T1 (de) | Xanthinderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische präparate. | |
| KR900016098A (ko) | 카페인산의 유도체 및 이를 함유하는 약제학적 조성물 | |
| ATE6645T1 (de) | Dibenzoxazepin-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
| ATE41772T1 (de) | Polymethoxybenzyl-piperazin-derivate, verfahren zu ihrer herstellung und diese derivate enthaltende pharmazeutische zusammensetzungen. | |
| DK0433167T3 (da) | Hidtil ukendte piperidinderivater, fremgangsmåde til fremstilling heraf og farmaceutiske midler indeholdende dem | |
| ATE116647T1 (de) | Thiophenderivate, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen. | |
| FR2612517B1 (fr) | Derives de benzoxazine, procedes de preparation de ces derives et compositions pharmaceutiques les contenant | |
| SE8300855L (sv) | Nya piperazin- och homopiperazinderivat, forfaranden for framstellning derav och farmaceutiska kompositioner innehallande dem | |
| FI853233L (fi) | 1,6-naftyridinderivat, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska produkter. | |
| ATE37368T1 (de) | Benzothiazolon-derivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen. | |
| ATE28871T1 (de) | Disubstituierte piperidine,verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
| ES2070959T3 (es) | Utilizacion de derivados del bis(4-hidroxifeniltio)metano en el tratamiento de la diabetes mellitus. | |
| ATE7224T1 (de) | Propanolamin-derivate, ihre salze, verfahren zu ihrer herstellung und pharmazeutische praeparate. | |
| ATE103909T1 (de) | Sulfonamide mit tetrazolylrest, verfahren zu ihrer herstellung sowie arzneimittel. | |
| SE8603589D0 (sv) | Metylendioxifenantren- och stilbenderivat | |
| PT93904A (pt) | Processo para a preparacao de novos derivados benzotiazolinonicos e de composicoes farmaceuticas que os contem | |
| SE8203477L (sv) | 4-aminobensylaminderivat, ett forfarande for deras framstellning och deras anvendning som farmaceutiska | |
| FR2655042B1 (fr) | Nouvelles benzothiazolinones substituees, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. | |
| ATE27278T1 (de) | Thieno(2,3-6)pyrrolderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen. | |
| ATE3295T1 (de) | Clavulansaeure-derivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate. |